» Articles » PMID: 9448000

POU Transcription Factors Brn-3a and Brn-3b Interact with the Estrogen Receptor and Differentially Regulate Transcriptional Activity Via an Estrogen Response Element

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1998 Feb 3
PMID 9448000
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The estrogen receptor (ER) modulates transcription by forming complexes with other proteins and then binding to the estrogen response element (ERE). We have identified a novel interaction of this receptor with the POU transcription factors Brn-3a and Brn-3b which was independent of ligand binding. By pull-down assays and the yeast two-hybrid system, the POU domain of Brn-3a and Brn-3b was shown to interact with the DNA-binding domain of the ER. Brn-3-ER interactions also affect transcriptional activity of an ERE-containing promoter, such that in estradiol-stimulated cells, Brn-3b strongly activated the promoter via the ERE, while Brn-3a had a mild inhibitory effect. The POU domain of Brn-3b which interacts with the ER was sufficient to confer this activation potential, and the change of a single amino acid in the first helix of the POU homeodomain of Brn-3a to its equivalent in Brn-3b can change the mild repressive effect of Brn-3a to a stimulatory Brn-3b-like effect. These observations and their implications for transcriptional regulation by the ER are discussed.

Citing Articles

Linking metabolic dysfunction with cardiovascular diseases: Brn-3b/POU4F2 transcription factor in cardiometabolic tissues in health and disease.

Budhram-Mahadeo V, Solomons M, Mahadeo-Heads E Cell Death Dis. 2021; 12(3):267.

PMID: 33712567 PMC: 7955040. DOI: 10.1038/s41419-021-03551-9.


Transcriptional regulation of prolactin in a euryhaline teleost: Characterisation of gene promoters through in silico and transcriptome analyses.

Seale A, Malintha G, Celino-Brady F, Head T, Belcaid M, Yamaguchi Y J Neuroendocrinol. 2020; 32(11):e12905.

PMID: 32996203 PMC: 8612711. DOI: 10.1111/jne.12905.


Transcription factors Brn-3α and TRIM16 in cancers, association with hormone reception.

Spirina L, Yunusova N, Kondakova I, Tarasenko N Heliyon. 2019; 5(8):e02090.

PMID: 31463379 PMC: 6708992. DOI: 10.1016/j.heliyon.2019.e02090.


ERα is required for suppressing OCT4-induced proliferation of breast cancer cells via DNMT1/ISL1/ERK axis.

Jin X, Li Y, Guo Y, Jia Y, Qu H, Lu Y Cell Prolif. 2019; 52(4):e12612.

PMID: 31012189 PMC: 6668970. DOI: 10.1111/cpr.12612.


Hsp-27 induction requires POU4F2/Brn-3b TF in doxorubicin-treated breast cancer cells, whereas phosphorylation alters its cellular localisation following drug treatment.

Fujita R, Ounzain S, Wang A, Heads R, Budhram-Mahadeo V Cell Stress Chaperones. 2011; 16(4):427-39.

PMID: 21279488 PMC: 3118820. DOI: 10.1007/s12192-011-0256-8.


References
1.
Day R, Koike S, Sakai M, Muramatsu M, Maurer R . Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol Endocrinol. 1990; 4(12):1964-71. DOI: 10.1210/mend-4-12-1964. View

2.
Verrijzer C, van der Vliet P . POU domain transcription factors. Biochim Biophys Acta. 1993; 1173(1):1-21. DOI: 10.1016/0167-4781(93)90237-8. View

3.
Wegner M, Drolet D, Rosenfeld M . POU-domain proteins: structure and function of developmental regulators. Curr Opin Cell Biol. 1993; 5(3):488-98. DOI: 10.1016/0955-0674(93)90015-i. View

4.
Lai J, Cleary M, Herr W . A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain. Genes Dev. 1992; 6(11):2058-65. DOI: 10.1101/gad.6.11.2058. View

5.
Keefer D, Holderegger C . The ontogeny of estrogen receptors: brain and pituitary. Brain Res. 1985; 351(2):183-94. DOI: 10.1016/0165-3806(85)90190-7. View